JBS Australia to Acquire Pork Producer Rivalea

JBS Australia Group is pleased to announce an agreement to acquire 100% of Rivalea Holdings Pty Ltd and 100% of Oxdale Dairy Enterprise Pty Ltd (together, “Rivalea”) from Singapore-based food and agricultural company QAF Limited. 

Rivalea Holdings owns two subsidiaries incorporated in Australia namely, Rivalea (Australia) Pty Ltd (held as to 100%) and Diamond Valley Pork Pty Ltd (held as to 80%) (together with Rivalea Holdings and Oxdale). 

Rivalea is a leading vertically integrated pork producer and processor with operations in both New South Wales and Victoria, supporting high quality pork production for the Australian domestic and international export markets. 

JBS Australia CEO Brent Eastwood said JBS plans to invest significantly in the Rivalea business to expand opportunities for both fresh and value added Australian pork products in domestic and international markets. 

“Rivalea is a leader in the Australian pork sector with a strong team and track record of sustainable pork production. JBS Australia is committed to building on these strong foundations and growing the business through new opportunities for Australian grown pork.  

“Our acquisition of Rivalea will enable us to expand into the breeding, growing, fattening and finishing of pigs, an area where JBS Australia does not currently operate. We intend to grow the use of domestic pork in JBS Australia’s operations, particularly within our Primo business, through further value-adding and processing, while unlocking new opportunities for Australian pork in international export markets. 

“JBS has a long and proud history of supporting and growing its Australian businesses – investing heavily in its local operations and domestic brands, while at the same time providing employment opportunities and supporting the regional economies in which we operate.” 

JBS Australia looks forward to working closely with Rivalea’s existing customers, suppliers and contractors. 

The acquisition is subject to relevant regulatory approvals including ACCC and FIRB.